Literature DB >> 17539789

Manifestation of Coats' disease by age in Taiwan.

Chien-Hsiung Lai1, Hsi-Kung Kuo, Pei-Chang Wu, Ming-Lun Kuo, Yung-Jen Chen.   

Abstract

BACKGROUND: To compare the differences in clinical manifestation of Coats' disease between younger and older patients in the Far East.
METHODS: Coats' disease cases diagnosed at one Taiwanese hospital from July 1986 to June 2004 were retrospectively reviewed (n=30; 32 eyes). Patients were stratified into groups according to the initial diagnosis of Coats' disease at the age of <20 years (Group Y) or >or=20 years (Group O). The clinical manifestations of Coats' disease in Group Y (19 eyes) and Group O (13 eyes) were compared.
RESULTS: A higher proportion of female patients was noted in Group O (P=0.046). Diseases were generally limited geographically, with 14 eyes (73.7%) manifesting involvement greater than 6 clock hours in Group Y and four eyes (30.8%) in Group O. The involved area including retinal telangiectasia and exudates was smaller in Group O (P=0.016). Patients without posterior pole involvement were associated with better visual outcome (adjusted odds ratio, 6.5; 95% confidence interval, 1.1-40.1, P=0.044).
CONCLUSION: Coats' disease manifestation was different between different age groups. Treatment is important to prevent disease progression. Visual prognosis is associated with posterior pole involvement.

Entities:  

Mesh:

Year:  2007        PMID: 17539789     DOI: 10.1111/j.1442-9071.2007.01485.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  5 in total

1.  Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease.

Authors:  Saemi Park; Han Joo Cho; Dong Won Lee; Chul Gu Kim; Jong Woo Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-03       Impact factor: 3.117

Review 2.  Paediatric retinal detachment: a review.

Authors:  Raffaele Nuzzi; Carlo Lavia; Roberta Spinetta
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

3.  Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats' disease in Korea.

Authors:  Hyun Goo Kang; Jung Dong Kim; Eun Young Choi; Suk Ho Byeon; Sung Soo Kim; Hyoung Jun Koh; Min Kim
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

4.  Fluorescein Angiographic Abnormalities in the Contralateral Eye with Normal Fundus in Children with Unilateral Coats' Disease.

Authors:  Eun Hye Jung; Jeong Hun Kim; Seong Joon Kim; Young Suk Yu
Journal:  Korean J Ophthalmol       Date:  2018-01-25

5.  The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.

Authors:  Longli Zhang; Yifeng Ke; Wei Wang; Xueying Shi; Kaiwen Hei; Xiaorong Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-16       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.